Advanced Oncotherapy PLC Fundamentals Datasheet and Stock Analysis

Profile

Advanced Oncotherapy PLC Company Logo
Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device and management of healthcare related property. The Company's segments include Development of Proton Therapy-UK; Development of Proton Therapy-Switzerland; Development of Proton Therapy-USA, and Healthcare-related properties-UK. Its LIGHT system uses accelerators, which is a series of modular units. This feature offers hospitals and centers to customize treatment plans based on a range of energies. The Company's Research and development/ADAM S.A. (R&D/ADAM) facility is located on the campus of European Council for Nuclear Research (CERN), Geneva, Switzerland, and a manufacturing plant, clinical research and clinician training facility in Syracuse, the United States.

  • Current Price:
     53.50p
  • Industry:
     Health Care
  • Sector:
     Health Care
  • ISIN:
     GB00BD6SX109
  • Market Sector:
     AIM
  • Main Indices:
     FTSE AIM
  • Country of register:
     Great Britain
  • Currency:
     N/A
  • Shares in Issue:
     151m
  • Market Cap:
     £79m
  • Date Listed:
     01/07/2016
Operation Breakdown
Geographical - by origin (turnover)
Product (turnover)

Loading...

Activity Data Not Available

Company Information

CEO: Nicolas Serandour  COO: Ed Lee  Non-Executive Director: Christopher Nutting, Hans von Celsing, Michael Bradfield, Euan Thomson, Nick Plowman, Enrico Cipro Vanni, Sanjeev Pandya Steve Myers OBE  Executive Chairman: Michael J Sinclair  

  • Registrars:
     
  • Address:
     CareCapital,6th Floor,54 Baker Street,London,United Kingdom
  • Phone:
     020 7034 1949
  • Website:
     http://www.carecapital.co.uk
Analysis
Composite Ranking: 44
Historic EPS Ranking: 41
Forecast EPS Ranking: 15
Price Relative Strength: 72
Industry Strength: E
SMR Ranking: 
ROCE Ranking: F
Accumulation/Dist: 
Mkt Accumulation/Dist: C
Unbroken Annual EPS: E
Unbroken Interim EPS: E
PEG Current Ranking: A
PEG Forecast Ranking: A
PE Current Ranking: A
PE Forecast Ranking: H
Margin Current Ranking: D
Margin Forecast Ranking: A
Chart
Add Indicator




loading




Takes the average of data over a period of time, and migrates the period across the data series one data point at a time. This formula smooths a data series and makes analysing volatile data easier.
Fundamentals
2011201220132014201520162017E2018E2019E
Day/Month31/1231/1231/1231/1231/1231/1231/1231/1231/12
Revenue£m0.070.100.070.000.000.00£m0.250.251.55
Operating Profit/(loss)£m(1.87)(1.56)(3.17)(5.84)(8.51)(13.09)£m0.000.000.00
Profit Before Tax£m(2.57)(1.88)(3.43)(5.70)(8.63)(13.18)£m(13.90)0.30(16.60)
Profit After Tax£m(2.28)(1.88)(3.43)(5.70)(5.85)(10.37)£m0.000.000.00
Profit After Tax (from discontinued operations)£m0.00(0.85)(0.54)(1.86)(0.71)0.02£m0.000.000.00
Overall Profit for the Period£m0.00(2.74)(3.97)(7.56)(6.56)(10.34)£m0.000.000.00
EPS Growth%0.000.000.000.000.000.00%0.000.000.00
Earnings Per Sharep(2.89)(26.69)(21.45)(16.71)(285.06)(17.05)p(15.90)1.20(8.50)
Op. Cash Flow P/Sp(0.08)0.000.000.000.000.00£0.000.000.00
Cash Flow P/S Grth%0.000.000.000.000.000.00%0.000.000.00
Net Cash Flow P/Sp0.000.000.000.000.000.00£0.000.000.00
Capital Exp P/S£0.000.000.000.000.000.00£0.000.000.00
Tax Rate%0.000.000.000.000.000.00%0.000.000.00
P/E Ratiox0.000.000.000.000.000.00x0.0050.000.00
P/E Growth£0.000.000.000.000.000.00£0.000.000.00
Turnover Per Share£0.010.000.000.000.000.00£0.000.000.00
Pre-Tax Profit / Share£(0.25)0.000.000.000.000.00£0.000.000.00
Operating Margin%0.00(1,564.52)(4,604.65)0.000.000.00%0.000.000.00
ROCE%0.00(51.40)(183.95)(196.55)(55.53)(117.99)%0.000.000.00
ROE%0.000.000.000.000.000.00%0.000.000.00
Mkt Cap£m0.0037.53121.99146.38286.20113.63£m0.000.000.00
Dividend Per Sharep0.000.000.000.000.000.00p0.000.000.00
DPS Growth%0.000.000.000.000.000.00%0.000.000.00
Dividend Yield%0.000.000.000.000.000.00%0.000.000.00
Dividend Coverx0.000.000.000.000.000.00x0.000.000.00
Shareholder Funds£m0.48(0.14)6.9111.1327.2833.99£m0.000.000.00
Net Borrowings£m0.00(0.06)(0.15)(1.47)(8.96)(1.45)£m0.000.000.00
Net Assets£m0.48(0.14)6.9111.1327.2833.99£m0.000.000.00
Net Assets P/S£0.000.000.000.000.000.00£0.000.000.00
Financials
Latest Forecast
Div Yield0.0%0.0%
Div Cover0.0%0.0%
Op Margin0.0%120.0%
ROCE0.0%
Director Deals
Traded Action Notifier Price Amount Value
11-Jan-18BuyEnrico Cipro Vanni54.50p 40,000£21,800
31-Jul-17BuyEnrico Cipro Vanni17.75p 100,000£17,750
15-May-17BuySteve Myers OBE26.00p 400,000£104,000
09-May-17BuyChristopher Nutting24.67p 202,500£49,956.75
09-May-17BuyChristopher Nutting0.25p202,500£49,956.75
25-Apr-17BuyMichael J Sinclair30.44p 200,000£60,880
24-Apr-17BuyEnrico Cipro Vanni26.96p 100,000£26,960
12-Apr-17BuyEnrico Cipro Vanni27.50p 100,000£27,500
04-Apr-17BuyEnrico Cipro Vanni29.25p 25,000£7,312.50
03-Apr-17BuyMichael J Sinclair28.35p 100,000£28,350
First PagePrev PageNext Page  Rows per page
Shareholders
151m    Major: 15%    Director: 9%
Notifier Holding Value
Michael Bradfield7,080,740£3,788,195.90
Michael J Sinclair4,928,229£2,636,602.52
Enrico Cipro Vanni1,263,946£676,211.11
Steve Myers OBE450,569£241,054.42
Christopher Nutting217,316£116,264.06
  Rows per page
Gearing & Cover
Broker Opinion
Date Broker Name Rec Price Old Price Target New Price Target Broker Change
25-Mar-15Westhouse SecuritiesBuy7.75p0.00p9.00pReiteration
  Rows per page
Notes

This functionality requires you to login

Click here to login
Or register for a new account